Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Non Operating Income (2016 - 2025)

Abeona Therapeutics has reported Non Operating Income over the past 12 years, most recently at $51000.0 for Q4 2025.

  • Quarterly results put Non Operating Income at $51000.0 for Q4 2025, down 92.31% from a year ago — trailing twelve months through Dec 2025 was $410000.0 (down 65.66% YoY), and the annual figure for FY2025 was $410000.0, down 65.66%.
  • Non Operating Income for Q4 2025 was $51000.0 at Abeona Therapeutics, down from $129000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for ABEO hit a ceiling of $2.2 million in Q2 2023 and a floor of -$118000.0 in Q2 2022.
  • Median Non Operating Income over the past 4 years was $145000.0 (2024), compared with a mean of $312466.7.
  • Biggest five-year swings in Non Operating Income: skyrocketed 1977.12% in 2023 and later crashed 92.31% in 2025.
  • Abeona Therapeutics' Non Operating Income stood at $277000.0 in 2022, then dropped by 22.74% to $214000.0 in 2023, then skyrocketed by 209.81% to $663000.0 in 2024, then crashed by 92.31% to $51000.0 in 2025.
  • The last three reported values for Non Operating Income were $51000.0 (Q4 2025), $129000.0 (Q3 2025), and $89000.0 (Q2 2025) per Business Quant data.